Evidence map›Paper›PMID 34354710›Full record

ArticleFrontiers in immunology2021

Viability Status-Dependent Effect of

Marcelina Joanna Pyclik, Dagmar Srutkova, Agnieszka Razim, Petra Hermanova, Tereza Svabova, Katarzyna Pacyga, Martin Schwarzer, Sabina Górska

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Nutrients · 2025
    Article
  4. Article
  5. The investigation of the role of oral-originatedFrontiers in microbiology · 2024
    Article
  6. Frontiers in microbiology · 2024
    Review
  7. Review
  8. Novel Probiotic BacteriumMicroorganisms · 2023
    Article
  9. Article
  10. Stress Response in Bifidobacteria.Microbiology and molecular biology reviews : MMBR · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Marcelina Joanna PyclikLaboratory of Microbiome Immunobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Dagmar SrutkovaLaboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, Novy Hradek, Czechia.
Agnieszka RazimLaboratory of Microbiome Immunobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Petra HermanovaLaboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, Novy Hradek, Czechia.
Tereza SvabovaLaboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, Novy Hradek, Czechia.
Katarzyna PacygaLaboratory of Microbiome Immunobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Martin SchwarzerLaboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, Novy Hradek, Czechia.
Sabina GórskaLaboratory of Microbiome Immunobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Czech Academy of Sciences · CZLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PLPolish Academy of Sciences · PLCzech Academy of Sciences, Institute of Microbiology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The classical definition of probiotics states that bacteria must be alive to be beneficial for human organism. However, recent reports show that inactivated bacteria or their effector molecules can also possess such properties. In this study, we investigated the physical and immunomodulatory properties of four

Indexed as

BifidobacteriumCell SurvivalHypersensitivityInflammationProbioticsAnimalsDisease Models, AnimalFemaleMiceMice, Inbred BALB CallergyBifidobacteriumheat inactivationintranasal administrationOvalbumin sensitizationprobiotic

Identifiers

PMID34354710
PMCPMC8329652
OpenAlexW3191775858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.